ID   TX2A_MYRPI              Reviewed;          75 AA.
AC   Q26464;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   07-APR-2021, entry version 67.
DE   RecName: Full=M-myrmeciitoxin-Mp2a {ECO:0000303|PubMed:26805882};
DE            Short=M-MIITX-Mp2a {ECO:0000303|PubMed:26805882};
DE   AltName: Full=Allergen Myr p II {ECO:0000303|PubMed:8605256};
DE   AltName: Full=DELTA-myrtoxin-Mp1a A chain {ECO:0000303|PubMed:28513074, ECO:0000303|PubMed:32629771};
DE            Short=Mp1a A chain {ECO:0000303|PubMed:28513074, ECO:0000303|PubMed:32629771};
DE   AltName: Full=Pilosin-3 subunit a {ECO:0000305};
DE            Short=Pilosulin-3a {ECO:0000303|PubMed:26805882, ECO:0000305};
DE   AltName: Full=Pilosulin-2 {ECO:0000303|PubMed:15019477};
DE   AltName: Allergen=Myr p 2 {ECO:0000303|PubMed:8605256};
DE   Flags: Precursor;
OS   Myrmecia pilosula (Jack jumper ant) (Australian jumper ant).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Holometabola; Hymenoptera; Apocrita; Aculeata; Formicoidea;
OC   Formicidae; Myrmeciinae; Myrmeciini; Myrmecia.
OX   NCBI_TaxID=13618;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 49-54, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=8605256; DOI=10.1016/0167-4781(95)00197-2;
RA   Street M.D., Donovan G.R., Baldo B.A.;
RT   "Molecular cloning and characterization of the major allergen Myr p II from
RT   the venom of the jumper ant Myrmecia pilosula: Myr p I and Myr p II share a
RT   common protein leader sequence.";
RL   Biochim. Biophys. Acta 1305:87-97(1996).
RN   [2]
RP   PARTIAL PROTEIN SEQUENCE, AND SUBUNIT.
RC   TISSUE=Venom;
RX   PubMed=8866004; DOI=10.1080/15216549600201022;
RA   Donovan G.R., Street M.D., Tetaz T., Smith A.I., Alewood D., Alewood P.F.,
RA   Sutherland S.K., Baldo B.A.;
RT   "Expression of jumper ant (Myrmecia pilosula) venom allergens: post-
RT   translational processing of allergen gene products.";
RL   Biochem. Mol. Biol. Int. 39:877-885(1996).
RN   [3]
RP   AMIDATION AT LEU-74, SUBUNIT, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   DISULFIDE BOND.
RC   TISSUE=Venom;
RX   PubMed=15019477; DOI=10.1016/j.toxicon.2003.11.021;
RA   Davies N.W., Wiese M.D., Brown S.G.A.;
RT   "Characterisation of major peptides in 'jack jumper' ant venom by mass
RT   spectrometry.";
RL   Toxicon 43:173-183(2004).
RN   [4]
RP   REVIEW, AND NOMENCLATURE.
RX   PubMed=26805882; DOI=10.3390/toxins8010030;
RA   Touchard A., Aili S.R., Fox E.G., Escoubas P., Orivel J., Nicholson G.M.,
RA   Dejean A.;
RT   "The biochemical toxin arsenal from ant venoms.";
RL   Toxins 8:1-28(2016).
RN   [5]
RP   FUNCTION, SYNTHESIS OF 49-74 IN COMPLEX WITH B CHAIN, BIOASSAY, AND TOXIC
RP   DOSE.
RX   PubMed=32629771; DOI=10.3390/biomedicines8070185;
RA   Nixon S.A., Dekan Z., Robinson S.D., Guo S., Vetter I., Kotze A.C.,
RA   Alewood P.F., King G.F., Herzig V.;
RT   "It takes two: dimerization is essential for the broad-spectrum predatory
RT   and defensive activities of the venom peptide Mp1a from the jack jumper ant
RT   Myrmecia pilosula.";
RL   Biomedicines 8:0-0(2020).
RN   [6]
RP   STRUCTURE BY NMR OF 49-74 IN COMPLEX WITH B CHAIN, FUNCTION, SYNTHESIS OF
RP   49-74 IN COMPLEX WITH B CHAIN, AND BIOASSAY.
RX   PubMed=28513074; DOI=10.1002/anie.201703360;
RA   Dekan Z., Headey S.J., Scanlon M., Baldo B.A., Lee T.H., Aguilar M.I.,
RA   Deuis J.R., Vetter I., Elliott A.G., Amado M., Cooper M.A., Alewood D.,
RA   Alewood P.F.;
RT   "Delta-myrtoxin-Mp1a is a helical heterodimer from the venom of the jack
RT   jumper ant that has antimicrobial, membrane-disrupting, and nociceptive
RT   activities.";
RL   Angew. Chem. Int. Ed. 56:8495-8499(2017).
CC   -!- FUNCTION: Heterodimer protein that may serve both defensive (pain-
CC       inducing) and predatory (insecticidal) roles (PubMed:28513074). Has
CC       membrane-disrupting activity and shows induction of non-specific
CC       calcium influx into cells, (PubMed:28513074). Shows broad-spectrum
CC       activity against a diverse range of bacteria, and cell lines, as well
CC       as hemolytic activity (EC(50)=2.18 uM) (PubMed:28513074). In vivo,
CC       shows moderate insecticidal activity against D.melanogaster and potent
CC       anthelmintic activity against the veterinary nematode H.contortus
CC       (PubMed:32629771). In addition, intraplantar injection into mice
CC       induces nocifensive behavior and mechanical allodynia
CC       (PubMed:28513074). {ECO:0000269|PubMed:28513074,
CC       ECO:0000269|PubMed:32629771}.
CC   -!- SUBUNIT: Heterodimer with M-MIITX-Mp2b (pilosin-3b) (AC P0C023);
CC       disulfide-linked (PubMed:8866004, PubMed:15019477). Only heterodimers
CC       (and not monomers) have been identified in the venom (PubMed:15019477).
CC       {ECO:0000269|PubMed:15019477, ECO:0000269|PubMed:8866004}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:8605256}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:8605256}.
CC   -!- ALLERGEN: The heterodimer causes an allergic reaction in human. Binds
CC       to IgE. It is speculated that the antigenic site is on the A chain.
CC       {ECO:0000269|PubMed:15019477}.
CC   -!- TOXIC DOSE: LD(50) of the heterodimer is 260.1 +- 16.6 pmol/g towards
CC       D.melanogaster. {ECO:0000269|PubMed:32629771}.
CC   -!- MISCELLANEOUS: Dekan et al., 2017 and Nixon et al., 2020 report
CC       synthesis and functional analysis of heterodimers with different
CC       disulfide patterns as well as different A and B chain monomeric forms.
CC       {ECO:0000305|PubMed:28513074, ECO:0000305|PubMed:32629771}.
CC   -!- SIMILARITY: Belongs to the formicidae venom precursor-01 superfamily.
CC       Ant pilosulin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S81785; AAB36316.1; -; mRNA.
DR   PIR; S65711; S65711.
DR   Allergome; 3381; Myr p 2.0101.
DR   Allergome; 3575; Myr p 2.0102.
DR   Allergome; 481; Myr p 2.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   GO; GO:0044179; P:hemolysis in other organism; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   Allergen; Amidation; Antibiotic; Antimicrobial; Cytolysis;
KW   Direct protein sequencing; Disulfide bond; Hemolysis; Secreted; Signal;
KW   Toxin.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   PROPEP          27..48
FT                   /evidence="ECO:0000305|PubMed:8605256"
FT                   /id="PRO_0000035164"
FT   PEPTIDE         49..74
FT                   /note="M-myrmeciitoxin-Mp2a"
FT                   /evidence="ECO:0000305|PubMed:8605256"
FT                   /id="PRO_0000035165"
FT   MOD_RES         74
FT                   /note="Leucine amide"
FT                   /evidence="ECO:0000269|PubMed:15019477"
FT   DISULFID        64
FT                   /note="Interchain (with C-17 in M-MIITX-Mp2b)"
FT                   /evidence="ECO:0000269|PubMed:15019477"
FT   DISULFID        71
FT                   /note="Interchain (with C-10 in M-MIITX-Mp2b)"
FT                   /evidence="ECO:0000269|PubMed:15019477"
SQ   SEQUENCE   75 AA;  8145 MW;  4FFE49969405F7AC CRC64;
     MKLSCLLLTL AIIFVLTIVH APNVEAKALA DPESDAVGFA DAVGEADPID WKKVDWKKVS
     KKTCKVMLKA CKFLG
//
